| scholarly article | Q13442814 |
| P50 | author | David S Weiss | Q87981838 |
| P2093 | author name string | Sarah E Anderson | |
| Philip N Rather | |||
| Edgar X Sherman | |||
| P2860 | cites work | Analyzing real-time PCR data by the comparative C(T) method | Q28131831 |
| Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options | Q30235064 | ||
| Persisters: a distinct physiological state of E. coli | Q33246517 | ||
| AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments. | Q33709547 | ||
| Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme | Q34057439 | ||
| Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
| Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii | Q35023321 | ||
| Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina | Q35035275 | ||
| Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii | Q35595613 | ||
| Genetic basis of persister tolerance to aminoglycosides in Escherichia coli | Q35597181 | ||
| Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii | Q35807220 | ||
| Phase-Variable Control of Multiple Phenotypes in Acinetobacter baumannii Strain AB5075. | Q35899795 | ||
| Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii | Q36035894 | ||
| Novel Aminoglycoside Resistance Transposons and Transposon-Derived Circular Forms Detected in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates | Q36644923 | ||
| Isolation of Acinetobacter from soil and water | Q36849097 | ||
| Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. | Q37058913 | ||
| Contribution of phenotypic heterogeneity to adaptive antibiotic resistance. | Q37475114 | ||
| Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae | Q37500145 | ||
| Gene amplification and adaptive evolution in bacteria. | Q37580926 | ||
| Clinical failure of vancomycin in a dialysis patient with methicillin-susceptible vancomycin-heteroresistant S. aureus | Q37581376 | ||
| Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli | Q37663571 | ||
| Multiple roles for a novel RND-type efflux system in Acinetobacter baumannii AB5075. | Q37747858 | ||
| Antimicrobial heteroresistance: an emerging field in need of clarity. | Q38310639 | ||
| Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure | Q38873222 | ||
| Construction of broad-host-range plasmid vectors for easy visible selection and analysis of promoters | Q39946175 | ||
| Isolation and Whole-genome Sequence Analysis of the Imipenem Heteroresistant Acinetobacter baumannii Clinical Isolate HRAB-85. | Q40123588 | ||
| Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus | Q40542104 | ||
| Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates | Q41515547 | ||
| Phenotype switching is a natural consequence of Staphylococcus aureus replication | Q42045562 | ||
| MODE OF ACTION OF STREPTOMYCIN ON TYPE b HEMOPHILUS INFLUENZAE : II. NATURE OF RESISTANT VARIANTS. | Q42287449 | ||
| Analysis and nucleotide sequence of an origin of DNA replication in Acinetobacter calcoaceticus and its use for Escherichia coli shuttle plasmids | Q42632910 | ||
| Variants of the gentamicin and tobramycin resistance plasmid pRAY are widely distributed in Acinetobacter. | Q43168256 | ||
| Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center | Q44563279 | ||
| Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin | Q45199316 | ||
| Unstable tandem gene amplification generates heteroresistance (variation in resistance within a population) to colistin in Salmonella enterica | Q46522626 | ||
| Importance of Core Genome Functions for an Extreme Antibiotic Resistance Trait | Q47131617 | ||
| A high-frequency phenotypic switch links bacterial virulence and environmental survival in Acinetobacter baumannii. | Q52716815 | ||
| Loss and gain of aminoglycoside resistance in global clone 2 Acinetobacter baumannii in Australia via modification of genomic resistance islands and acquisition of plasmids. | Q53085326 | ||
| Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. | Q53987303 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| P577 | publication date | 2018-08-15 | |
| P1433 | published in | mSphere | Q27727104 |
| P1476 | title | Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075 | |
| P478 | volume | 3 |
| Q90265393 | Ceftazidime/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing Klebsiella pneumoniae and Hinders Emergence of Resistant Subpopulation in vitro |
| Q92563144 | Heteroresistance: A cause of unexplained antibiotic treatment failure? |
| Q98202475 | Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment |
| Q91451154 | The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification |
Search more.